Highest-materiality recent filing
BBWI Q1 sales down 3%, adjusted EPS $0.32 beats guidance; CFO Boratto to step down June 12
Q1 net sales $1.378B (-3% YoY); GAAP EPS $0.90, adjusted EPS $0.32 (beating guidance).
BBWI Q4 adj EPS $2.05 beats; FY2026 sales guide down 2.5-4.5%, adj EPS $2.40-2.65
Q4 net sales $2.724B (-2% YoY); adj EPS $2.05 vs prior year $2.09 but above company guidance.
Bath & Body Works launches transformation plan; Q3 EPS $0.37, cuts FY25 guidance
Q3 net sales $1.594B (-1% YoY); GAAP EPS $0.37 ($0.35 adj); operating income $161M vs $218M prior year.
BBWI Q2 net sales +1.5% to $1.55B, adj EPS $0.37 (high end); raises FY adj EPS low end
Q2 GAAP EPS $0.30 vs $0.68 last year; adj EPS $0.37 flat YoY.
Bath & Body Works Q1 net sales up 3% to $1.42B, EPS up 29% to $0.49; maintains FY guidance
Net sales $1,424M (+2.9% YoY); EPS $0.49 (+29% YoY) vs $0.38 prior year.
Bath & Body Works names Daniel Heaf CEO; Q1 EPS $0.49 beats high-end guidance
Daniel Heaf appointed CEO effective May 16, 2025, replacing Gina Boswell who stepped down.
Bath & Body Works Q4 2024 beats guidance; provides FY2025 outlook
Q4 net sales $2,788M (down 4.3% YoY on 13 vs 14 weeks); GAAP EPS $2.09 vs $2.55.
Bath & Body Works redeems all outstanding 9.375% Senior Notes due 2025 on Jan 30
Notice of redemption for any and all outstanding 9.375% Senior Notes due 2025.
Bath & Body Works Q3 sales up 3% to $1.61B, EPS $0.49 beats guidance; raises FY guidance
Q3 net sales $1,610M (+3% YoY); EPS $0.49 vs $0.52 ($0.48 adjusted) prior year, exceeding guidance.
Bath & Body Works Q2 adjusted EPS $0.37 beats guidance; lowers FY2024 outlook
Q2 net sales $1,526M, down 2.1% YoY; adjusted EPS $0.37 vs. $0.40 last year, above guidance.
Bath & Body Works Q1 EPS $0.38 beats high-end guidance; narrows FY2024 range upward
Q1 net sales $1,384M (-0.9% YoY) above guidance; diluted EPS $0.38 (GAAP), up 9% YoY.
the Board of Directors (the "Board") of the Company approved the appointment of Tom Javitch to serve as the Company’s Interim Chief Financial Officer
Ms. Boratto provided notice of her intent to resign from the Company to pursue another professional opportunity, effective as of the Transition Date, on May 20, 2026.
resigned as a member of the Board effective the same day
the Board of Directors of the Company (the “Board”) has appointed Daniel Heaf to serve as Chief Executive Officer of the Company, effective May 16, 2025
Gina Boswell ceased to serve as Chief Executive Officer of the Company effective as of May 16, 2025
Mr. Heaf will be appointed as a member of the Board effective as of immediately following the conclusion of the Company’s 2025 Annual Meeting of Shareholders
Effective on January 31, 2025, Deon Riley ceased to serve as Chief Human Resources Officer of Bath & Body Works, Inc.
Julie Rosen ceased to serve as President, Retail of Bath & Body Works, Inc. (the “Company”) on September 25, 2024.
Max materiality 0.85 · Median 0.65 · Most common event earnings